Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Access Capital Partners is a leading independent European investment manager specializing in private equity, private debt, and infrastructure. Founded in 1998 and headquartered in Paris, the firm provides institutional investors with access to the European mid-market through primary fund investments, secondary transactions, and direct co-investments. While not a biotechnology developer itself, Access Capital Partners maintains a significant presence in the healthcare and life sciences sectors through its diversified investment portfolios. The firm operates a pan-European platform with a team of approximately 90 professionals across offices in major financial hubs including London, Brussels, and Helsinki.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Access Capital Partners.